Mercy Medical Group now offers patients undergoing chemotherapy the DigniCap Scalp Cooling System, which reduces the likelihood of chemotherapy-induced hair loss in men and women with solid tumor cancers such as those associated with breast, prostate, ovarian, uterine, lung and other tissues.
Most patients who use DigniCap will see a significant reduction in the amount of hair loss from chemotherapy. However, shedding should be expected and is completely normal for patients using scalp cooling. The amount of shedding experienced will vary from patient to patient.
Chemotherapy may cause scalp irritation, make the hair dry, brittle and more difficult to manage. Handling your hair gently during treatment and for several months after you complete your chemotherapy regimen may help reduce the amount of shedding and maintain your hair quality.
If you are a patient undergoing chemotherapy and would like more information on the DigniCap Scalp Cooling System, talk to your oncologist. If you need help finding an oncologist, call (888) 314-3627 or use our Find a Doctor tool.